Brief: Genetic Signatures Says TGA Registered Saliva-Based Protocol Kit For Collecting COVID Samples
10/01/2022 01:15
Jan 10 (Reuters) - Genetic Signatures Ltd GSS.AX :
* TGA RECENTLY REGISTERED A SALIVA-BASED PROTOCOL KIT FOR
COLLECTING SAMPLES FOR SARS-COV-2
Source text for Eikon: ID:nASX4KQvT3
Further company coverage: GSS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Anne Lockwood To Conclude As Interim Managing Director
Brief: Genetic Signatures Logs Q3 Sales A$3 Mln
Australia's Genetic Signatures extends gain on deal with Danish hospital
Australia's Genetic Signatures jumps on supply agreement with Denmark hospital
Brief: Genetic Signatures Signs Danish Supply Agreement